Logo image
Prof. Dr. med. Nadia Harbeck, MD, PhD working place, University Hospital Ludwig-Maximilians Munich
Prof. Dr. med. Nadia Harbeck, MD, PhD
Excellent
AiroScore
9.70

Prof. Dr. med. Nadia Harbeck, MD, PhD

oncology, breast cancer, obstetrics and gynecology
oncology, breast cancer, obstetrics and gynecology
User ScoreExperienceRatingPrice RangePublicationsMedia FilesOnline Consultations
93%37 years9.7/10$$$$35858No

Overview

Country, City
Germany, Munich
Health facility
University Hospital Ludwig-Maximilians Munich
Medical unit
Breast center

About the doctor

Prof. Dr. med. Nadia Harbeck, MD, PhD, is a highly accomplished oncologist specializing in breast cancer treatment. With an impressive career spanning decades, she has held various prestigious positions, including Director of the Breast Center at University Hospital Ludwig-Maximilians Munich. Her research focuses on biomarkers for therapy decision-making in breast cancer, leading to groundbreaking outcomes. Through her scientific publications, she has significantly contributed to the understanding and treatment of this disease, earning her accolades and awards for clinical research and excellence. Prof. Harbeck's expertise in oncology and her groundbreaking breast cancer research make her a sought-after physician in Germany. Her dedication to improving patient outcomes and her role in shaping the future of breast cancer treatment highlight her as a leader in the field. With a wealth of experience and a passion for innovation, Prof. Dr. med. Nadia Harbeck continues to make significant contributions to oncology, benefiting patients and advancing medical knowledge.

Gallery

Resume

CV (Curriculum Vitae)

Education
  • 1983-1989 Medical School, Ludwig-Maximilians-University, Munich, Germany
  • 1983-1989 Bavarian Merit Scholarship for highly gifted students
  • 1992 German National Board certification as physician (Approbation)
  • 1993 Fellowship of the European School of Oncology
  • 1993 M.D. (Dr. med.), Ludwig-Maximilians-University, Munich, Germany
  • 1994-1995 Research Fellowship, Technical University Munich
  • 1998 Specialist for Obstetrics and Gynecology, German National Board certification
  • 1998 M.D., Ph.D. (Habilitation, Dr. med. habil., Privatdozent), TUM
  • 1999-2002 Research Group Leader, “Tumor Invasion and Metastasis,” TUM
  • 2000 Consultant (Oberarzt) for Obstetrics and Gynecology, TUM
  • 2003 Associate Professor for OB&GYN, Technical University of Munich, Germany
  • 2005-2009 Head of Conservative Senology, TUM
  • 2009 Board certification (Zusatzbezeichnung) for “Medical Tumor Therapy”
  • 2010-2011 Training Permit (Weiterbildungsberechtigung) “Medical Tumor Therapy”, Cologne
  • 2019 Board certification (Zusatzbezeichnung) for Genetic Counseling OB&GYN (fachgebundene genetische Beratung)
  • 2019 Training Permit (Weiterbildungsberechtigung) “Medical Tumor Therapy”, LMU
Experience
  • 1992-1998 Resident, Department of Obstetrics and Gynecology, TUM
  • 1998-1999 Specialist, Department of Obstetrics and Gynecology, TUM
  • 2000-2004 Consultant, Department of Obstetrics and Gynecology, TUM
  • 2005-2009 Head of Conservative Senology, Department of Obstetrics and Gynecology, TUM
  • 2009-2011 Head of Breast Center, Oncological Therapy and Clinical Trials Unit, Department of Obstetrics and Gynecology, Cologne University, Germany
  • 2011-present Director, Breast Center, University of Munich (LMU), Germany
  • 2011-present Head, Oncological Therapy & Clinical Trials Unit, Dept. OB&GYN, LMU
  • 2011-present Full Professor, Chair for Conservative Oncology (Dept. OB&GYN), LMU
  • 2012-present Steering Committee Member, Comprehensive Cancer Center LMU (CCCLMU)
  • 2019-present Chair, Center for Hereditary Breast and Ovarian Cancer, LMU
  • 2020-present Member, Clinical Trial Sponsorship Commission, LMU University Hospital
  • 2022-present Member, Research Commission, LMU Medical Faculty
  • 2023-2025 ESMO Director of Education, ESMO Executive Board Member
Awards & Memberships
  • 1994 Scientific Award of the Bavarian Society of Obstetrics & Gynecology
  • 1995 Young Investigators Award of the Clinical Cytometry Society, USA
  • 1997 “Best Abstract”, German Society of Senology
  • 2001 AACR Scholar-In-Training Award for Promising Clinical or Translational Research
  • 2001 ASCO Fellowship Merit Award for the highest ranking abstract
  • 2001 AstraZeneca Scholar Award, 24th San Antonio Breast Cancer Symposium
  • 2002 Preceptorship (R. Ozols, MD), Fox Chase Cancer Center, Philadelphia, USA
  • 2002 Schmidt Matthiesen Award for Gynecological Oncology
  • 2002-2004 “Innovators in Breast Cancer” (Chair: G. Hortobagyi, Houston, USA)
  • 2008 Emmanuel van der Schueren Invited Lecture (EBCC Award), EBCC 6, Berlin
  • 2008 Keynote Lecture “Breast Cancer”, German Cancer Congress, Berlin
  • 2009 Opening Lecture (in memory of Lale Atahan), IBCM-2, Sarajevo
  • 2010 Keynote Speaker, Danish Cancer Society, Copenhagen
  • 2011-present Panel/Faculty Member: Advanced Breast Cancer Consensus (ABC), Lisbon
  • 2012 Claudia von Schilling Award, MHH Hannover, Germany
  • 2012-present Panel/Faculty Member: Breast Cancer in Young Women Conference (BCY)
  • 2015 Patient Award, Bavarian Cancer Society
  • 2015 Medicine Management Award
  • 2015 Keynote Speaker, Asian Pacific Breast Cancer Symposium (APBCS), Brisbane
  • 2015 Keynote Speaker, Russian Society Clinical Oncology (RUSSCO), Moscow
  • 2015-present Panel/Faculty Member: St. Gallen Consensus on Primary Breast Cancer, Vienna
  • 2017 Keynote Speaker, PragueONCO, Prague
  • 2018 Keynote Speaker, European Breast Cancer Conference EBCC11, Barcelona
  • 2019 Keynote Speaker, Women for Women, Rome
  • 2020 ESMO Lifetime Achievement Award
  • 2021 UPO Alumni Award for Women in Academy and Research
  • 2021 “Best Abstract”, German Society of Senology
  • 2021-2024 Highly Cited Researcher
  • 2023 German Cancer Award (Deutscher Krebspreis) for Clinical Research
  • 2024-present Adjunct Professor, Medical University of Vienna, Austria
  • 2025 Bavarian Order of Merit (Bayerischer Verdienstorden)
  • 2009-2011 Steering Committee Member, Center for Integrated Oncology, Cologne/Bonn
  • 2009-2011 Steering Committee Member, Clinical Trials Center, University of Cologne
  • 2009-2011 Member Ethics Committee (IRB), Medical Faculty, University of Cologne
  • 2014-2018 Executive Board Member, Munich Comprehensive Cancer Center, CCCMunich
  • 2016-2022 Member Ethics Committee (IRB), Medical Faculty, LMU

Languages

English flag
English
German flag
German

Publications

Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer.

26 February, 2026

Neoadjuvant trastuzumab deruxtecan alone or followed by paclitaxel, trastuzumab, and pertuzumab for high-risk HER2-positive early breast cancer (DESTINY-Breast11): a randomised, open-label, multicentre, phase III trial.

February, 2026

Association of potential biomarkers with clinical outcomes in metastatic triple-negative breast cancer treated with pembrolizumab or chemotherapy.

2 October, 2025

Location

Ziemssenstraße, 5, 80336 Munich, Germany

FAQ

What is the specialization of Prof. Dr. med. Nadia Harbeck, MD, PhD?

The primary specialization of the doctor is oncology, breast cancer, obstetrics and gynecology.

What is the experience of the specialist?

Prof. Dr. med. Nadia Harbeck, MD, PhD has been practicing for more than 37 years.

What is the rating of the doctor?

Is the specialist involved in the research?

Where can I see the work of the doctor?

Does the specialist offer online consultations?

No, Prof. Dr. med. Nadia Harbeck, MD, PhD doesn’t perform virtual appointments.

Prof. Dr. med. Nadia Harbeck, MD, PhD
Prof. Dr. med. Nadia Harbeck, MD, PhD

Get individual treatment plan and cost estimate. Non-binding 100% free assessment.

© Prof. Dr. med. Nadia Harbeck, MD, PhD

Similar Doctors

Excellent
AiroScore
9.90
Excellent
AiroScore
9.90
University Hospital Rechts der Isar Munich
urological oncology, immunotherapy, penile cancer
Excellent
AiroScore
9.90
University Hospital Rechts der Isar Munich
sarcoma, orthopaedics and trauma surgery, orthopedic oncology
Excellent
AiroScore
9.80
University Hospital Rechts der Isar Munich
uro-oncology, robotics function-preserving pelvic surgery
Excellent
AiroScore
9.80
University Hospital Ludwig-Maximilians Munich
internal medicine, hematology, oncology, infectiology, intensive care, and emergency medicine
Excellent
AiroScore
9.80
University Hospital Rechts der Isar Munich
surgical urology, tumor immunology, tumor genetics, minimally invasive endourological diagnostics and therapy, urooncology